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a b s t r a c t
Defects of the ventral body wall are prevalent birth anomalies marked by deﬁciencies in body wall
closure, hypoplasia of the abdominal musculature and multiple malformations across a gamut of organs.
However, the mechanisms underlying ventral body wall defects remain elusive. Here, we investigated
the role of Wnt signaling in ventral body wall development by inactivating Wls or β-catenin in murine
abdominal ectoderm. The loss of Wls in the ventral epithelium, which blocks the secretion of Wnt
proteins, resulted in dysgenesis of ventral musculature and genito-urinary tract during embryonic
development. Molecular analyses revealed that the dermis and myogenic differentiation in the under-
lying mesenchymal progenitor cells was perturbed by the loss of ectodermalWls. The activity of the Wnt-
Pitx2 axis was impaired in the ventral mesenchyme of the mutant body wall, which partially accounted
for the defects in ventral musculature formation. In contrast, epithelial depletion of β-catenin or Wnt5a
did not resemble the body wall defects in the ectodermal Wls mutant. These ﬁndings indicate that
ectodermal Wnt signaling instructs the underlying mesodermal speciﬁcation and abdominal muscula-
ture formation during ventral body wall development, adding evidence to the theory that ectoderm-
mesenchyme signaling is a potential unifying mechanism for the origin of ventral body wall defects.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Ventral body wall closure defects include highly variable
phenotypes, which can be categorized as gastroschisis, amniocent-
esis, omphalocele, umbilical hernia, limb-body wall defect and
prune belly syndrome. For example, prune belly syndrome (PBS,
OMIM 100100) is a speciﬁc body wall defect with characteristics of
ventral body wall musculature deﬁciency or hypoplasia, various
urinary tract abnormalities and bilateral cryptorchidism in males
(Hassett et al., 2012). According to the accumulated literature on
ventral body wall defects, most of these body wall closure defects
are thought to be of embryonic origin (Sadler and Feldkamp,
2008). Before E12.0 during mouse embryogenesis, the parietal
layer of the lateral plate mesoderm, together with the surface
ectoderm, forms the somatopleure and migrates ventrally to give
rise to the primary body wall (Eng et al., 2012; Sadler, 2010). Then,
abdominal myogenic progenitor cells move into the somatopleure
and progressively differentiate into secondary body wall, including
the three layers of abdominal musculature, dermis and epithelium.
The bilateral ventral body walls join at the midline, and the body
wall is fully closed at E16.5 (Brewer and Williams, 2004a; Sadler,
2010; Sadler and Feldkamp, 2008).
In contrast to the long list of clinical reports and experimental
studies, molecular hypotheses for ventral body wall defects are
controversial. Four types of theories have been presented as the
etiology of these deﬁciencies: embryonic dysplasia, vascular dis-
ruption, mechanical disruption and malfunction of the ectodermal
placodes (Brewer and Williams, 2004a). Recently, a novel hypoth-
esis has been proposed that crosstalk between the epithelium and
mesenchyme is a vital signaling process essential for normal
development and closure of the ventral body wall (Brewer and
Williams, 2004a). This theory is based on the observation that
inactivation of the transcription factor AP-2α leads to one of the
most severe ventral body wall closure defects, thoracoabdomi-
noschisis. Histological and molecular analyses suggest that AP-2α
is required for signaling from the surface ectoderm to the under-
lying mesoderm for proper development and closure of ventral
body wall (Brewer and Williams, 2004b).
Wnt signaling has a pivotal role in embryonic myogenesis and
myoblast differentiation of skeletal muscles. In mouse paraxial
mesoderm, Wnt1 from the embryonic dorsal neural tube and
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Wnt7a in the dorsal ectoderm induce somite myogenesis
(Tajbakhsh et al., 1998). Ectodermal Wnt6 is required for myogenic
induction in the limb bud (Geetha-Loganathan et al., 2006;
Geetha-Loganathan et al., 2005). In concert with Shh signaling,
canonical Wnt/β-catenin signaling regulates myogenic differentia-
tion and proliferation through direct induction of Myf5 expression
within the epaxial dermomyotome (Borello et al., 2006). Non-
canonical Wnt11, together with Wnt6 secreted from the surface
ectoderm, maintains the essential epithelial nature of the dor-
somedial and ventrolateral lips of the dermomyotome and acts as
a directional cue for the elongation of easy muscle ﬁbers (Gros
et al., 2009). Furthermore, the Wnt/Lef1-Pitx2 pathway has been
suggested to regulate somite myogenesis (Abu-Elmagd et al.,
2010). The loss of Pitx2 resulted in a deﬁciency in ventral body
wall closure and agenesis of abdominal musculatures (Eng et al.,
2012). However, the role of the Wnt-Pitx2 pathway in abdominal
muscle formation remains unclear.
Here, we inactivated Wntless (Wls) gene expression in the
mouse abdominal ectoderm through the Msx2-cre transgene
(Lewandoski et al., 2000). Wls is required for the secretion of
various Wnt proteins (Banziger et al., 2006; Bartscherer et al.,
2006; Franch-Marro et al., 2008; Fu et al., 2011; Gasnereau et al.,
2012), and depletion of the Wls allele is sufﬁcient to block the
paracrine effect of Wnt signaling during multiple developmental
processes (Augustin et al., 2012; Fu et al., 2009; Huang et al., 2012;
Maruyama et al., 2012; Myung et al., 2012; Zhong et al., 2012; Zhu
et al., 2012). The deﬁciency of epithelial Wls led to deformities in
abdominal musculature in the secondary ventral body wall, which
are typical characteristics of prune belly syndrome. Our ﬁndings
provide novel insight into the role of Wnt-mediated epithelium–
mesenchyme signaling during ventral body wall development.
Materials and methods
Mice
Wlsc/c and Wnt5aþ / mice were generated as previously
described (Zhu et al., 2012). Wlsc/c (C57BL/6) mice were crossed
with a Msx2-cre transgenic mouse. Msx2-cre; Wlsc/þ offspring
were backcrossed to Wlsc/c mice to generate the Msx2-cre; Wlsc/c
knockout mice. The ﬂoxed status of the Wls conditional allele was
genotyped with the following primers: P1: 50-ATACTTTTTCT-
GATCTGTTGT-30 and P2: 50-AAGTTTTAATAGGTCTGTGTT-30. The
presence of Msx2-cre was identiﬁed by PCR using the following
primers: F: 50-CAAAAGTTGGAGTCTTCGCT-30 and R: 50-CAGAAG-
CATTTTCCAGGTAT-30. Catnbc/c mice were generated and genotyped
as previously described (Guo et al., 2004). The Wnt5a knockout
mice were genotyped with the primers: P1: 50-TTCCAAGTTCTTCC-
TAATGGC-30 and P2: 50-TTGGGTGGAGAGGCTATTCG-30. The mice
were maintained in a speciﬁc pathogen-free environment with
free access to food and water and a 12 h/12 h light–dark cycle.
Animal welfare and experimental procedures were conducted
strictly in accordance with the care and use of laboratory animals
and the related ethical regulations of Shanghai Jiao Tong
University.
LacZ staining, histology and immunohistochemistry
Whole mount X-gal staining was performed as described
previously (Day et al., 2005). After re-ﬁxing the stained samples,
the samples were either photographed or sectioned to observe Cre
enzyme activity. Wild-type and mutant embryos were harvested
at speciﬁc stages and ﬁxed with 4% PFA in PBS. The ﬁxed samples
were dehydrated, embedded in parafﬁn, and cut into 10 μm thick
sections. H&E staining was performed on rehydrated samples. For
immunohistochemistry (IHC), sections were rehydrated, blocked
with 5% goat serum, and incubated overnight at 4 1C with anti-Wls
(Santa Cruz, USA), anti-Lef1 (CST, USA), anti-Myosin (Epitomics,
CA, USA), anti-keratin5 (Covance, NJ, USA), anti-BrdU (CST, USA),
and anti-MyoD (BD, USA) primary antibodies according to the
recommended dilution. Alexa Fluor 488 (Invitrogen, USA) was
used as the secondary antibody. A TUNEL assay kit (Promega, WI,
USA) was used to label apoptotic cells. The labeled samples were
then counterstained with DAPI, and a Leica SP5 confocal micro-
scope was used to observe and document the results.
qRT-PCR and in situ hybridization
Total RNA isolated from E12.5 and E13.5 mouse abdominal skin
was extracted using TRIzol reagent (Invitrogen, CA, USA). cDNA
was reverse transcribed using SuperScript™ III First-Strand Synth-
esis System for RT-PCR (Invitrogen, CA, USA). qRT-PCR was
performed on an Applied Biosystems 7500 using SYBR reagents.
β-actin was used as a control. Whole-mount RNA in situ hybridi-
zations and section RNA in situ hybridizations were performed as
described previously using probes for MyoD, Myogenin, Wls,
Dermo1 and Pitx2 (Zhu et al., 2012). Pitx2 cDNA was ampliﬁed
with the primers: F: 50-AGAAACCGCTACCCAGAC-30 and R: 50-
TCAGAAACAAGGCATCCA-30.
Results
A variety of Wnt genes are expressed in the ventral body wall
To identify the nature of Wnt proteins that contribute to ventral
body wall development, we examined the expression levels of all
19 Wnt genes in the developing ventral body wall by qRT-PCR. At
E13.5, the expression of Wnt2, Wnt3, Wnt5a, Wnt6, Wnt7b and
Wnt11 were relatively higher in the abdominal body wall (Fig. 1A).
Wnt6 expression in the ventral body wall ectoderm from E11.5 to
E13.5 was validated by in situ hybridization (arrow in Fig. 1C–I). In
contrast, Wnt5a expression existed in somites and the dorsal
mesenchyme (Fig. 1D), but was not strongly detected in the ventral
most ectoderm at E13.5 (Fig. 1H), consistent with a previous report
(Witte et al., 2009). Wls expression has been detected in a variety
of tissues and cell types during organogenesis (Yu et al., 2010). We
also detected that Wls was expressed in the ventral body wall,
especially in the abdominal ectoderm (arrows in Fig. 2I and K).
These results showed that Wls and several Wnt genes, such as
Wnt6, are expressed in the developing ventral body wall.
Ectodermal inactivation of Wls impairs ventral body wall
development
To investigate the role of Wnt proteins in ventral body wall
development, Msx2-cre was used to inactivate Wls to block Wnt
secretion in the ectoderm of the ventral body wall. X-gal staining
of Msx2-cre; R26R reporter mice showed that the Cre activity ﬁrst
appeared in the ventral body wall between the hindlimbs at E11.5
(Fig. 2A and B). Thereafter, its expression progressively expanded
to the entire ventral body wall between the forelimbs and
hindlimbs from E12.5 to E13.5 (Fig. 2C–F). Consistent with its
expression pattern in the limb ectoderm (Barrow et al., 2003), Cre
activity was also detected in the ectoderm of the ventral body wall
in the Msx2-cre; R26R mice (Fig. 2G and H).
The Msx2-cre mice were crossed to Wlsc/c mice to generate
Msx2-cre; Wlsc/þ mice. The heterozygous mice did not display
defects in growth and development. By backcrossingWlsc/c mice to
Msx2-cre; Wlsc/þ mice, Msx2-cre; Wlsc/c homozygous mutants
were generated and identiﬁed to be perinatal lethal. In the
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knockout embryos, Wls expression was efﬁciently depleted in the
ectoderm of the ventral body wall, indicated by IHC with a Wls
antibody (arrows in Fig. 2I and J) and by in situ hybridization with
a Wls probe (arrows in Fig. 2K and L). qRT-PCR validated the
decrease in expression levels of Wls, Lef1 and Axin2 in the mutant
ventral body wall compared to the controls (Fig. 2M, po0.05,
n¼3). Furthermore, diminished LacZ staining was observed in
ventral epithelium of Msx2-cre; Wlsc/c; Topgal relative to Wlsc/c;
Topgal embryos at E14.5 (arrows in Fig. 2P and Q), indicating the
downregulation of canonical Wnt signaling activity.
Fig. 1. Relative abundance of Wnt expression in the ventral body wall ectoderm. (A) qRT-PCR revealed that a variety of Wnts was expressed in the ventral body wall at E13.5.
(B–I) Wnt6 (C, E, G, I) but notWnt5a (B, D, F, H) was remarkably expressed in the distal ventral ectoderm of the developing ventral body wall from E11.5 to E13.5. Panels H–I
correspond to cross-sections along the lines in F–G.
Fig. 2. Cre activity in the ventral body wall ectoderm in the Msx2-Cremice. (A–F) X-gal staining ofMsx2-cre; R26R embryos at E11.5 (A, B), E12.5 (C, D) and E13.5 (E, F) showing
Cre activity in the abdominal body wall ectoderm. A–E, ventral view; B–F, lateral view. (G–H) Transverse sections of the embryo trunk at E11.5 (G) and E13.5 (H) corresponding
to panels B and F. (I–L) The expression of the Wls protein (I, J) and mRNA (K, L) was signiﬁcantly reduced in the ventral body wall ectoderm in the Msx2-cre; Wlsc/c mutant
embryo at E12.5, indicating effective deletion of Wls by Msx2-cre. (M) qRT-PCR analysis indicated that the expression of Wls, Lef1 and Axin2 was downregulated in the ventral
body wall in the control andMsx2-cre;Wlsc/c mutant E12.5 embryos. N¼3. (N–O) LacZ staining forWlsc/c; Topgal andMsx2-cre;Wlsc/c; Topgal embryos at E14.5. (P–Q) Section of
LacZ staining in N–O. White lines indicated the position of sections.
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The homozygous Msx2-cre; Wlsc/c embryos exhibited varied
deformities in ventral body wall development, categorized as
severe, moderate and mild phenotypes according to the width of
secondary ventral body wall and the extent of lateral muscle
migration at E18.5 (Fig. 3). More than 30 mutant mice were
analyzed and the percentage of each type are as following: severe
(40%) , moderate (40%), mild(20%). The severe and moderate
mutants had outward extension of the visceral organs in the belly
(Fig. 3B–D), which was covered by a nearly transparent abdominal
body wall (Fig. 3F–H). The body wall in the mutants was composed
of a thin layer of epithelium at the most ventral part, whereas the
body wall was relatively normal in the lateral part. Meanwhile, the
most ventral part of the body wall in the mild mutant consisted of
a thin layer of epithelium and underlying mesenchyme (Fig. 3M–P
and U–X). In addition, genitalia formation was disrupted in the
Msx2-cre; Wlsc/c embryos (arrows in Fig. 3I–L). According to HE
staining of abdominal sections at E17.5, the bladder was dilated
and the bladder mesenchyme was diminished in the mutants
compared to the controls (arrows in Fig. 3Y and Z). These
deﬁciencies in Msx2-cre; Wlsc/c mice were 100% penetrant. The
range of severity was concordant between ventral body wall and
genito-urinary tracts. The structure of the ventral body wall in the
severe mutants resembled the primary abdominal body wall in
wild-type embryos before E12.5, indicating agenesis of the
secondary ventral body wall. Together, these data indicated that
the loss of Wls in epithelium impairs secondary body wall and
genito-urinary system development.
Ectodermal loss of Wls disrupts abdominal myogenesis
The secondary ventral body wall is formed by mesenchyme
derived from the lateral plate mesoderm and myogenic progenitor
cells originating from the dermomyotome. To dissect the devel-
opmental defects in the Msx2-cre; Wlsc/c embryos, myogenic
differentiation and migration were evaluated in cross-sections by
IHC or in situ hybridization. Epidermal development appeared
normal in the mutant ventral body wall, as indicated by the
normal expression of K5 (Fig. 4A–D), a keratinocyte marker in
the skin. However, muscle formation was remarkably diminished
in the ventral most part of the body wall, as revealed by an anti-
MLC antibody (Fig. 4E–H).
Myogenic progenitor cells migrate ventrally along the muscu-
lature formation in secondary ventral body wall. To dissect the
molecular pathways involved in the myogenic defects in the
mutant ventral body wall, several myoblast markers were
employed in IHC or in situ hybridization. MyoD is an early
myoblast marker while Myogenin is expressed in differentiated
myoblasts. Defects in myogenic development in the mutants were
Fig. 3. Abnormal abdominal body wall phenotypes in the Msx2-cre; Wlsc/c embryos. (A–D) Lateral view of the wild-type and Msx2-cre; Wlsc/c mutant embryos at E18.5.
Arrows indicate abdominal body walls with severe, moderate, and mild phenotypes. (E–H) Ventral high-magniﬁcation view of the mouse body wall corresponding to panels
A–D. The abdominal body wall in Msx2-cre; Wlsc/c mutant embryos is nearly transparent. (I–L) Defects in the genito-urinary tracts in the Msx2-cre; Wlsc/c mutant embryos.
(M–P) HE staining of transverse sections of the trunk (50 magniﬁcation). (Q–T) High-magniﬁcation view of the box 1 lateral region in M–P (200 magniﬁcation). (U–X)
High-magniﬁcation view the of box 2 ventral region in M–P (200 magniﬁcation). Indiscernible muscle and ventral dermis were formed in the mutant ventral body wall
compared to the controls. (Y–Z) HE staining of sections of the genito-urinary system in the mutants. Black arrows mark the enlarged bladder, and purple arrows show the
defective urinary tracts.
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found at E13.5 and E14.5 and were marked by the excluded
expression of Myogenin in the furthermost ventral body wall
(Fig. 5H0–I0). The distance of the Myogenin positive cells from the
ventral front to the dorsal midline was shorter in the mutants at
E13.5 compared to the wild-type controls (dual arrows in
Fig. 5H–I0). In contrast, MyoD expression in the lateral ventral
body wall was not remarkably different between wild-type and
mutant, as evidenced by in situ hybridization in embryos from
E11.5 to E13.5 (arrows in Fig. 5A–C0) and IHC analysis in E12.5
sections (Fig. 6A and B). However, mesenchymal cell migration and
differentiation underlying the ventral ectoderm was disrupted in
the furthermost ventral part of the body wall in the Msx2-cre;
Wlsc/c embryos, as indicated by the signiﬁcant exclusion of Dermo1
and Pitx2 expression from the ventral most mesenchyme (arrows
in Fig. 6L–M0). Pitx2 has been reported to be expressed in somite-
derived myogenic progenitor cells and act as an early inducer of
myogenic differentiation (Eng et al., 2012). In line with the start of
ventral musculature deﬁciency, Pitx2 expression level was com-
parable in lateral body wall between the wild type and mutant
embryos at E11.5 and E12.5 (arrows in Supplemental Fig. S1). But it
was excluded from ventral body wall of E13.5 mutant (double head
arrows in Supplemental Fig. S1). These ﬁndings suggested that the
loss of ectodermal Wls disrupted late abdominal myogenic differ-
entiation during secondary ventral body wall development.
Depletion of epithelial Wls does not affect the proliferation and
survival of abdominal myogenic progenitor cells
To investigate the cellular mechanisms underlying the abdom-
inal myogenesis defects, cell proliferation and death were exam-
ined by BrdU labeling and a TUNEL assay. In E12.5 sections, the
MyoD expression domain in the ventral body wall was outlined,
and BrdU positive cells were counted in a similar region in
consecutive sections (Fig. 6A–D). Meanwhile, BrdU positive cells
were also counted in the underlying mesenchyme of the ventral
body wall (Fig. 6E and F). Statistical analysis showed that cell
proliferation was not altered in the Msx2-cre; Wlsc/c embryos
compared to the controls (Fig. 6G, p40.05, n¼3). Moreover, no
differences were detected in cell death in the ventral body wall, as
revealed by the TUNEL assay (Fig. 6H–K, p40.05, n¼3). These data
indicated that cell proliferation and survival were not primary
contributors to the abdominal musculature defects in the mutant.
Ablation of epithelial β-catenin or Wnt5a has no effect on ventral
body wall development
The loss of Wls decreased the activity of canonical Wnt
signaling in the ventral body wall (Figs. 2M, 5K and K0). To test
whether the musculature defects in the mutant ventral body wall
resulted from the cell autonomous effect of Wnt signaling ablation
in the ectoderm, we revisited Msx2-cre; Catnbc/c mice with
β-catenin deﬁciency in ventral body wall ectoderm. The Msx2-
cre; Catnbc/c mutant mice had no limb formation (Fig. 7A and B),
which was in line with a previous report (Barrow et al., 2003).
However, the mice displayed no obvious defects in ventral body
wall development compared to the controls, as evidenced by HE
staining and IHC with anti-MLC on transverse sections (Fig. 7C–H).
Therefore, the ventral body wall defects caused by the loss of
epithelial Wls may not have resulted from the intrinsically defec-
tive Wnt signaling in the ectoderm, but may have been the
consequence of blocking ectodermal Wnt secretion.
We also investigated the ventral body wall structure in
Wnt5a / mice by HE staining and IHC analysis on transverse
sections at E16.5. Similarly, no remarkable defect in ventral body
wall was detected in Wnt5a null mice (Fig. 7I–N). These results
also indicated that Wnt5a, the non-canonical Wnt, may not be the
major Wnt protein that signals from epithelium to mesenchyme
during ventral body wall development.
Discussion
In this study, we investigated Msx2-cre; Wlsc/c, Msx2-cre;
Catnbc/c and Wnt5a/ embryos and compared their defects in
ventral body wall development. Based on these genetic and
molecular analyses, we conclude that ectodermal Wnt signaling
instructs the differentiation and speciﬁcation of the underlying
mesenchyme in a paracrine manner during ventral body wall
formation. These data shed new insight into our understanding of
the molecular mechanisms of myogenesis. The Wnt/Pitx2 pathway
might be commonly employed in myogenesis through ectoderm-
Fig. 4. Impaired muscle development in the ventral body wall of Msx2-cre; Wlsc/c mutants. (A–D) Immunoﬂuorescence staining for K5, a marker of the basal layer, showed
relatively normal epithelium formation in the Msx2-cre; Wlsc/c mutant. (E–H) Immunostaining with a myosin antibody indicated that the development of the ventral body
wall muscle was perturbed in the mutant. DAPI, blue; K5 or myosin, green.
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mesoderm crosstalk across multiple systems, including somites,
limbs and the ventral body wall. Furthermore, these results add
new evidence for the potential unifying theory that claims that
most of the ventral body wall deﬁciencies arise from defective
epithelial–mesenchymal signaling.
Ectodermal Wnt signaling regulates abdominal myogenesis during
secondary ventral body wall development
The developmental processes of limb myogenesis and abdom-
inal myogenesis share many aspects, which involve the coordi-
nated migration of lateral plate mesoderm and myogenic
differentiation from the dermomyotome. Wnt signaling is an
important regulator of myogenic differentiation and muscle ﬁber
elongation in somitogenesis and limb formation (Borello et al.,
2006; Brand-Saberi and Christ, 1999; Francis-West et al., 2003;
Gros et al., 2009; van der Velden et al., 2008). Ectodermal Wnt6 is
essential for limb myogenesis (Geetha-Loganathan et al., 2006;
Geetha-Loganathan et al., 2005). Our previous study reported that
the Msx2-cre; Wlsc/c mice display deﬁciencies in limb myogenesis
(Zhu et al., 2012).Msx2-crewas originally detected to be expressed
in the limb ectoderm (Barrow et al., 2003). Here, we identiﬁed
that Msx2-cre also had Cre activity in the abdominal ectoderm.
Our further investigations revealed defects in abdominal muscula-
ture formation and dysplasias in the ventral body wall in Msx2-cre;
Wlsc/c embryos. Therefore, Wls-mediated ectodermal Wnt signaling
regulates myogenesis during both limb and ventral body wall
development.
According to our qRT-PCR examinations, several Wnts, including
Wnt2, Wnt3, Wnt5a, Wnt6, Wn7b and Wnt11, were comparatively
enriched in the developing ventral body wall (Fig. 1A). The expression
of Wnt6 in the ectoderm was validated by in situ hybridization
(Fig. 1B). In the Msx2-cre; Wlsc/c embryos, canonical Wnt signaling
activity was signiﬁcantly decreased in the underlying mesenchyme
of the ventral body wall (Fig. 2M), and abnormalities in the
dermis speciﬁcation and myogenic differentiation were identiﬁed
(Fig. 5K–M0). In contrast, the loss of β-catenin in the ectoderm of
Msx2-cre; Catnbc/c embryos caused no comparable defects in the
ventral body wall as that in the epithelium-speciﬁc Wls null embryos
(Fig. 7A–H). However, Wnt5a is a typical non-canonical Wnt that is
involved in the regulation of distal mesenchyme extension or the
outgrowth of multiple organs (Gao, 2012; Yamaguchi et al., 1999).
However, the Wnt5a null embryos also had no remarkable defects in
ventral body wall myogenesis (Fig. 7I–N). Wnt5a expression was also
absent from the ventral ectoderm (Fig. 1F and H). Therefore, non-
canonical Wnt5a signaling might not contribute to ventral body wall
development. These analyses indicate that ectodermal canonical Wnt
ligands, most likely Wnt6, regulate ventral body wall development
through epithelia-mesenchymal signaling. Of course, to validate this
hypothesis, ventral body wall development could be investigated in
embryos that were implanted with beads soaked with Wnt6 protein
or anti-Wnt6 antibody.
Fig. 5. Myoblast migration and differentiation is impaired in the ventral body wall of Msx2cre/þ; Wlsc/c mutants. (A–C0) MyoD expression, which represented myoblast
progenitor cells, was relatively normal in the ventral body wall from E11.5 to E13.5 in theMsx2-cre;Wlsc/c mutant compared to the controls. (G–I0)Myogenin expression, which
marked differentiated muscle ﬁbers, was excluded from the far most ventral body wall in the Msx2-cre; Wlsc/c mutant at E13.5 and E14.5 (double arrows). However, its
expressionwas comparatively normal at E12.5. (J–J0) MyoD expressionwas comparable in the ventral body wall between sections from the control andMsx2-cre;Wlsc/c mutant
at E12.5. (K–K0) Immunoﬂuorescence staining showed that the expression of Lef1 was signiﬁcantly reduced in the mutant. (L–L0) Dermo1 mRNA was absent from the ventral
mesenchyme at E12.5 in a Msx2-cre; Wlsc/c mutant (dashed lines). (M–M0) Pitx2 expression was not detected in the far most ventral mesenchyme in a E12.5 mutant (arrows).
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The Wnt-Pitx2 signaling pathway has been reported to regulate
cell proliferation in limb myogenesis and somite myogenesis (Abu-
Elmagd et al., 2010; Briata et al., 2003; Kioussi et al., 2002). Pitx2
has been identiﬁed as one cause of Reiger syndrome, which
includes defects in the ventral body wall in addition to eye,
craniofacial and cardiac abnormalities (Gage and Camper, 1997;
Semina et al., 1996). Furthermore, the loss of Pitx2 in mice leads to
deﬁciencies in abdominal musculature formation and closure of
the ventral body wall (Eng et al., 2012; Kitamura et al., 1999). In
our results, the deﬁciency of ectodermal Wls led to a decrease in
Pitx2 and Lef1 expression in the ventral mesenchyme and myo-
genic progenitor cells (Fig. 5L–M0). Taken together, our ﬁndings
suggest that the Wnt/β-catenin-Pitx2 pathway, at least in part,
mediated the signaling from the overlaying ectoderm to instruct
abdominal myogenesis. The Wnt-Pitx2 pathway might commonly
regulate myogenesis in multiple tissues, including limbs, somites
and the ventral body wall.
Ectodermal Wnt signaling is a potential etiological factor for PBS
Animal mutants displaying typical PBS-like deﬁciencies are rarely
reported. The transcriptional factor HNF1β, which regulates embry-
ogenesis and visceral endoderm speciﬁcation (Cofﬁnier et al., 1999;
Mefford et al., 2007), contributes to the etiology of some clinical cases
of PBS, especially in patients with renal cystic dysplasia and prostatic
hypoplasia (Granberg et al., 2012; Haeri et al., 2010). The most
common cause of prune belly syndrome (PBS) was previously
thought to be urethral obstruction malformation, which results in
an enormous bladder and ureteral dilation that distends the fetal
abdomen (King and Prescott, 1978; Pagon et al., 1979). However, our
observations did not support this hypothesis. In our study, speciﬁc
inactivation of Wls in the mouse abdominal ectoderm led to typical
PBS-like phenotypes. The loss of epithelial Wls affected the differ-
entiation of myogenic progenitor cells in the underlying mesench-
yme, as well as the formation of the genito-urinary system. Previous
report also reveals that epithelial Wnt signaling directs external
genitalia formation (Miyagawa et al., 2009). Therefore, the defective
epithelial–mesenchymal signaling seems to be a more important
cause for PBS etiology. Wnt/Pitx2 axis might be a potential genetic
factor contributing to the pathology of PBS.
Epithelial-mesenchymal signaling may be a unifying mechanism for
the origin of ventral body wall defects
Several animal models of ventral body wall closure defects have
been established. For example, TGF-β2/TGF-β3 double knockout mice
Fig. 6. Loss of ectodermal Wls has no impact on mesodermal cell proliferation. (A–B) The MyoD-expressing domain in the ventral body wall at E12.5. (C–D) BrdU labeling in
the presumptive MyoD expression domain at E12.5 (dashed line). (E–F) BrdU labeling in mesenchymal cells in the ventral body wall at E12.5. (G) Cell proliferation in MyoD-
expressing and mesenchymal cells was not signiﬁcantly different in the mutants compared to the controls at E12.5. (H–K) TUNEL staining showed that cell apoptosis was not
signiﬁcantly altered in the ventral body wall at E13.5.
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and AP2-α knockout mice both display the most severe defects in
ventral body wall development (Brewer and Williams, 2004b;
Dunker and Krieglstein, 2002). IGF-II receptor/IGF-II mutants
(Eggenschwiler et al., 1997) and Bmp1 null mice (Suzuki et al.,
1996) exhibit abnormalities across different organs in the ventral
body wall. This evidence suggests that multiple signaling pathways,
including TGF-β, IGF and Bmp signaling, are involved in regulating
ventral body wall development. Further investigations employing
conditional knockout mice of these signaling pathways would
provide better understanding of their contributions to the develop-
ment of the ventral body wall. And more, studies have showed that
multiple signaling pathways, including Hh and Wnt signaling
regulate development of external genitalia through epithelial–
mesenchymal interaction (Miyagawa et al., 2009; Suzuki et al.,
2009). On the other hand, several other mutants, including Shroom
(Hildebrand and Soriano, 1999), PS1 (Hartmann et al., 1999), Hic1
(Carter et al., 2000), Zic3 (Klootwijk et al., 2000), Alx4 (Qu et al., 1997),
Hoxb2/b4 (Manley et al., 2001) and p57KIP2 (Zhang et al., 1997),
present partially penetrant body wall phenotypes. These genetic
factors are also possible mesenchymal factors that are responsive to
ectodermal signaling in regulating ventral body wall formation.
Together with these reports, our ﬁndings support the theory that
disrupted epithelial–mesenchymal signaling may be a unifying
mechanism that accounts for most ventral body wall defects.
Fig. 7. Loss of ectodermal β-catenin or Wnt5a has no obvious impact on the ventral body wall. (A–B) Ventral view of a Msx2-cre; Catnbc/c embryo at E17.5 showed the loss of
hindlimbs and a relatively normal ventral body wall. (C–D) HE staining of transverse sections of Msx2-cre; Catnbc/c embryos. (E–F) Enlarged view of boxed region in (C–D).
(G–H) Immunostaining for myoblasts by a MLC antibody at E17.5. (I–J) HE staining of transverse sections of theWnt5a/ embryos at E16.5. (K–L) Enlarged view of the boxed
region in I–J. (M–N) Immunostaining of myoblasts by a MLC antibody at E16.5. These analyses indicated normal muscle development or migration in the ventral body walls of
Wnt5a or epithelial Wls mutants. (O) Diagram showed that epithelial Wnt signaling regulated underlying myogenesis and dermis speciﬁcation during ventral body wall
development through β-catenin-Pitx2 axis.
L. Zhang et al. / Developmental Biology 387 (2014) 64–72 71
Acknowledgments
This work was supported by the National Major Fundamental
Research 973 program of China under Grants [2014CB942902 and
2012CB966903], and by Grants from the National Natural Science
Foundation of China [31171396, 81121001 and 31100624].
Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.ydbio.2013.12.027.
References
Abu-Elmagd, M., et al., 2010. Wnt/Lef1 signaling acts via Pitx2 to regulate somite
myogenesis. Dev. Biol. 337, 211–219.
Augustin, I., et al., 2012. The Wnt secretion protein Evi/Gpr177 promotes glioma
tumourigenesis. EMBO Mol. Med. 4, 38–51.
Banziger, C., et al., 2006. Wntless, a conserved membrane protein dedicated to the
secretion of Wnt proteins from signaling cells. Cell 125, 509–522.
Barrow, J.R., et al., 2003. Ectodermal Wnt3/beta-catenin signaling is required for the
establishment and maintenance of the apical ectodermal ridge. Genes Dev. 17,
394–409.
Bartscherer, K., et al., 2006. Secretion of Wnt ligands requires Evi, a conserved
transmembrane protein. Cell 125, 523–533.
Borello, U., et al., 2006. The Wnt/beta-catenin pathway regulates Gli-mediated
Myf5 expression during somitogenesis. Development 133, 3723–3732.
Brand-Saberi, B., Christ, B., 1999. Genetic and epigenetic control of muscle
development in vertebrates. Cell Tissue Res. 296, 199–212.
Brewer, S., Williams, T., 2004a. Finally, a sense of closure? Animal models of human
ventral body wall defects. Bioessays 26, 1307–1321.
Brewer, S., Williams, T., 2004b. Loss of AP-2alpha impacts multiple aspects of
ventral body wall development and closure. Dev. Biol. 267, 399–417.
Briata, P., et al., 2003. The Wnt/beta-catenin4Pitx2 pathway controls the turnover
of Pitx2 and other unstable mRNAs. Mol. Cell 12, 1201–1211.
Carter, M.G., et al., 2000. Mice deﬁcient in the candidate tumor suppressor gene
Hic1 exhibit developmental defects of structures affected in the Miller–Dieker
syndrome. Hum. Mol. Genet. 9, 413–419.
Cofﬁnier, C., et al., 1999. Essential role for the homeoprotein vHNF1/HNF1beta in
visceral endoderm differentiation. Development 126, 4785–4794.
Day, T.F., et al., 2005. Wnt/beta-catenin signaling in mesenchymal progenitors
controls osteoblast and chondrocyte differentiation during vertebrate skeleto-
genesis. Dev. Cell 8, 739–750.
Dunker, N., Krieglstein, K., 2002. Tgfbeta2 / Tgfbeta3/ double knockout mice
display severe midline fusion defects and early embryonic lethality. Anat.
Embryol. (Berl.) 206, 73–83.
Eggenschwiler, J., et al., 1997. Mouse mutant embryos overexpressing IGF-II exhibit
phenotypic features of the Beckwith–Wiedemann and Simpson–Golabi–Beh-
mel syndromes. Genes Dev. 11, 3128–3142.
Eng, D., et al., 2012. Loss of abdominal muscle in Pitx2 mutants associated with
altered axial speciﬁcation of lateral plate mesoderm. PLoS One 7, e42228.
Franch-Marro, X., et al., 2008. Wingless secretion requires endosome-to-Golgi
retrieval of Wntless/Evi/Sprinter by the retromer complex. Nat. Cell Biol. 10,
170–177.
Francis-West, P.H., et al., 2003. Regulation of myogenic differentiation in the
developing limb bud. J. Anat. 202, 69–81.
Fu, J., et al., 2011. Gpr177/mouse Wntless is essential for Wnt-mediated craniofacial
and brain development. Dev. Dyn..
Fu, J., et al., 2009. Reciprocal regulation of Wnt and Gpr177/mouse Wntless is
required for embryonic axis formation. Proc. Natl. Acad. Sci. USA 106,
18598–18603.
Gage, P.J., Camper, S.A., 1997. Pituitary homeobox 2, a novel member of the bicoid-
related family of homeobox genes, is a potential regulator of anterior structure
formation. Hum. Mol. Genet. 6, 457–464.
Gao, B., 2012. Wnt regulation of planar cell polarity (PCP). Curr. Top. Dev. Biol. 101,
263–295.
Gasnereau, I., et al., 2012. Identiﬁcation of an endocytosis motif in an intracellular
loop of Wntless protein, essential for its recycling and the control of Wnt
protein signaling. J. Biol. Chem. 286, 43324–43333.
Geetha-Loganathan, P., et al., 2006. Role of Wnt-6 in limb myogenesis. Anat.
Embryol. (Berl.) 211, 183–188.
Geetha-Loganathan, P., et al., 2005. Ectodermal Wnt-6 promotes Myf5-dependent
avian limb myogenesis. Dev. Biol. 288, 221–233.
Granberg, C.F., et al., 2012. Genetic basis of prune belly syndrome: screening for
HNF1beta gene. J. Urol. 187, 272–278.
Gros, J., et al., 2009. WNT11 acts as a directional cue to organize the elongation of
early muscle ﬁbres. Nature 457, 589–593.
Guo, X., et al., 2004. Wnt/beta-catenin signaling is sufﬁcient and necessary for
synovial joint formation. Genes Dev. 18, 2404–2417.
Haeri, S., et al., 2010. Deletion of hepatocyte nuclear factor-1-beta in an infant with
prune belly syndrome. Am. J. Perinatol. 27, 559–563.
Hartmann, D., et al., 1999. Presenilin-1 deﬁciency leads to loss of Cajal–Retzius
neurons and cortical dysplasia similar to human type 2 lissencephaly. Curr. Biol.
9, 719–727.
Hassett, S., et al., 2012. Prune belly syndrome. Pediatr. Surg. Int. 28, 219–228.
Hildebrand, J.D., Soriano, P., 1999. Shroom, a PDZ domain-containing actin-binding
protein, is required for neural tube morphogenesis in mice. Cell 99, 485–497.
Huang, S., et al., 2012. Wls is expressed in the epidermis and regulates embryonic
hair follicle induction in mice. PLoS One 7, e45904.
King, C.R., Prescott, G., 1978. Pathogenesis of the prune-belly anomalad. J. Pediatr.
93, 273–274.
Kioussi, C., et al., 2002. Identiﬁcation of a Wnt/Dvl/beta-Catenin 4Pitx2 pathway
mediating cell-type-speciﬁc proliferation during development. Cell 111,
673–685.
Kitamura, K., et al., 1999. Mouse Pitx2 deﬁciency leads to anomalies of the ventral
body wall, heart, extra- and periocular mesoderm and right pulmonary
isomerism. Development 126, 5749–5758.
Klootwijk, R., et al., 2000. A deletion encompassing Zic3 in bent tail, a mouse model
for X-linked neural tube defects. Hum. Mol. Genet. 9, 1615–1622.
Lewandoski, M., et al., 2000. Fgf8 signalling from the AER is essential for normal
limb development. Nat. Genet. 26, 460–463.
Manley, N.R., et al., 2001. Hoxb2 and hoxb4 act together to specify ventral body
wall formation. Dev. Biol. 237, 130–144.
Maruyama, T., et al., 2012. Gpr177, a novel locus for bone-mineral-density and
osteoporosis, regulates osteogenesis and chondrogenesis in skeletal develop-
ment. J. Bone Miner. Res..
Mefford, H.C., et al., 2007. Recurrent reciprocal genomic rearrangements of 17q12
are associated with renal disease, diabetes, and epilepsy. Am. J. Hum. Genet. 81,
1057–1069.
Miyagawa, S., et al., 2009. Dosage-dependent hedgehog signals integrated with
Wnt/beta-catenin signaling regulate external genitalia formation as an appen-
dicular program. Development 136, 3969–3978.
Myung, P.S., et al., 2012. Epithelial Wnt ligand secretion is required for adult hair
follicle growth and regeneration. J. Invest. Dermatol..
Pagon, R.A., et al., 1979. Urethral obstruction malformation complex: a cause of
abdominal muscle deﬁciency and the “prune belly”. J. Pediatr. 94, 900–906.
Qu, S., et al., 1997. Polydactyly and ectopic ZPA formation in Alx-4 mutant mice.
Development 124, 3999–4008.
Sadler, T.W., 2010. The embryologic origin of ventral body wall defects. Semin.
Pediatr. Surg. 19, 209–214.
Sadler, T.W., Feldkamp, M.L., 2008. The embryology of body wall closure: relevance
to gastroschisis and other ventral body wall defects. Am. J. Med. Genet. C
Semin. Med. Genet. 148C, 180–185.
Semina, E.V., et al., 1996. Cloning and characterization of a novel bicoid-related
homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nat.
Genet. 14, 392–399.
Suzuki, K., et al., 2009. New horizons at the caudal embryos: coordinated
urogenital/reproductive organ formation by growth factor signaling. Curr. Opin.
Genet. Dev. 19, 491–496.
Suzuki, N., et al., 1996. Failure of ventral body wall closure in mouse embryos
lacking a procollagen C-proteinase encoded by Bmp1, a mammalian gene
related to Drosophila tolloid. Development 122, 3587–3595.
Tajbakhsh, S., et al., 1998. Differential activation of Myf5 and MyoD by different
Wnts in explants of mouse paraxial mesoderm and the later activation of
myogenesis in the absence of Myf5. Development 125, 4155–4162.
van der Velden, J.L., et al., 2008. Glycogen synthase kinase 3 suppresses myogenic
differentiation through negative regulation of NFATc3. J. Biol. Chem. 283,
358–366.
Witte, F., et al., 2009. Comprehensive expression analysis of all Wnt genes and their
major secreted antagonists during mouse limb development and cartilage
differentiation. Gene. Expr. Patterns 9, 215–223.
Yamaguchi, T.P., et al., 1999. A Wnt5a pathway underlies outgrowth of multiple
structures in the vertebrate embryo. Development 126, 1211–1223.
Yu, H.M., et al., 2010. Expression of Gpr177, a Wnt trafﬁcking regulator, in mouse
embryogenesis. Dev. Dyn. 239, 2102–2109.
Zhang, P., et al., 1997. Altered cell differentiation and proliferation in mice lacking
p57KIP2 indicates a role in Beckwith–Wiedemann syndrome. Nature 387,
151–158.
Zhong, Z., et al., 2012. Wntless functions in mature osteoblasts to regulate bone
mass. Proc. Natl. Acad. Sci. USA 109, E2197–E2204.
Zhu, X., et al., 2012. Wls-mediated Wnts differentially regulate distal limb pattern-
ing and tissue morphogenesis. Dev. Biol. 365, 328–338.
L. Zhang et al. / Developmental Biology 387 (2014) 64–7272
